Cullinan Oncology shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cullinan Oncology
Tip: Access up to 7 years of quarterly data
All positions including Cullinan Oncology held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cullinan Oncology by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $257k | 25k | 10.19 |
| 2023-09-30 | $220k | 24k | 9.05 |
| 2023-06-30 | $223k | 21k | 10.76 |
| 2023-03-31 | $228k | 22k | 10.23 |
| 2022-12-31 | $204k | 19k | 10.54 |
| 2022-06-30 | $235k | 18k | 13.04 |
| 2022-03-31 | $255k | 24k | 10.54 |
| 2021-12-31 | $309k | 20k | 15.40 |
| 2021-03-31 | $1.6M | 38k | 41.65 |